(A)= The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it.

AttributesValues
type
label
  • Propoxycarbazone (A) (propoxycarbazone, its salts and 2-hydroxypropoxycarbazone expressed as propoxycarbazone) (en)
  • Propoxycarbazone (Α) (propoxycarbazone, τα άλατά του και 2-hydroxypropoxycarbazone εκφραζόμενο ως propoxycarbazone) (el)
  • Propoksükarbasoon (A) (propoksükarbasoon, selle soolad ja 2-hüdroksüpropoksükarbasoon, väljendatud propoksükarbasoonina) (et)
  • Propoksikarbazon (A) (propoksikarbazon, njegove soli in 2-hidroksi-propoksikarbazon, izraženi kot propoksikarbazon) (sl)
  • Propoxicarbazona (A) (propoxicarbazona, sus sales y 2-hidroxi-propoxicarbazona expresada en forma de propoxicarbazona) (es)
  • Propoksykarbazon (A) (propoksykarbazon, jego sole oraz 2-hydroksypropoksykarbazon wyrażony jako propoksykarbazon) (pl)
  • Propoksikarbazon (A) (propoksikarbazon, njegove soli i 2-hidroksipropoksikarbazon izražen kao propoksikarbazon) (hr)
  • Propoxicarbazona (A) (propoxicarbazona, seus sais e 2-hidroxi-propoxicarbazona, expressos em propoxicarbazona) (pt)
  • Propoxycarbazon (A) (Propoxycarbazon, seine Salze und 2-Hydroxypropoxycarbazon, ausgedrückt als Propoxycarbazon) (nl)
  • propoxykarbazón (A) (propoxykarbazón, jeho soli a 2-hydroxypropoxykarbazón vyjadrené ako propoxykarbazón) (sk)
  • Propoksikarbazons (A) (propoksikarbazons, tā sāļi un 2-hidroksipropoksikarbazons izteikts kā propoksikarbazons) (lv)
  • Propoxicarbazon (A) (propoxicarbazon, sărurile sale și 2-hidroxipropoxicarbazon, exprimate ca propoxicarbazon) (ro)
  • Пропоксикарбазон (A) (пропоксикарбазон, неговите соли и 2-хидроксипропоксикарбазон, изразени като пропоксикарбазон) (bg)
  • Propoxikarbazon (A) (propoxikarbazon, dess salter och 2-hydroxipropoxikarbazon, uttryckt som propoxikarbazon) (sv)
  • Propossikarbażon (A) (propossikarbażon, l-imluħa tiegħu u 2-idrossipropossikarbażon espressi bħala propossikarbażon) (mt)
  • Propoxycarbazon (propoxycarbazon, salte heraf og 2-hydroxypropoxy-propoxycarbazon, beregnet som propoxycarbazon) (da)
  • Propoksikarbatsoni (A) (propoksikarbatsoni, sen suolat ja 2-hydroksipropoksikarbatsoni ilmaistuna propoksikarbatsonina) (fi)
  • Propoksikarbazonas (A) (propoksikarbazonas, jo druskos ir 2-hidroksipropoksikarbazonas, išreikšta kaip propoksikarbazonas) (lt)
  • Propoxycarbazone (A) (propoxycarbazone, i suoi sali e 2-idrossipropoxycarbazone, espressi in propoxycarbazone) (it)
  • Propoxycarbazon (A) (propoxycarbazon, zouten daarvan en 2-hydroxypropoxycarbazon, uitgedrukt als propoxycarbazon) (de)
  • Propoxi-karbazon (A) (propoxi-karbazon, sói és 2-hidroxi-propoxi-karbazon propoxi-karbazonként kifejezve) (hu)
  • Propoxycarbazone (A) (propoxycarbazone, ses sels et 2-hydroxy-propoxycarbazone exprimés en propoxycarbazone) (fr)
  • Propoxykarbazon (A) (propoxykarbazon, jeho soli a 2-hydroxypropoxykarbazon, vyjádřeno jako propoxykarbazon) (cs)
comment
  • The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (fi)
  • (A)= The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (bg)
  • (A)= The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (de)
  • (A)= The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (el)
  • (A)= The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (en)
  • (A)= The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (es)
  • (A)= The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (hu)
  • (A)= The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (lt)
  • (A)= The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (lv)
  • (A)= The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (mt)
  • (A)= The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (ro)
  • (A)= The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (sk)
  • (A)= The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (sl)
  • (A)= The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (sv)
  • (A) The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (fr)
  • (A)=The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (cs)
  • (A)=The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (da)
  • (A)=The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (et)
  • (A)=The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (hr)
  • (A)=The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (it)
  • (A)=The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (nl)
  • (A)=The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (pl)
  • (A)=The EU reference labs identified the reference standard for 2-hydroxy-propoxycarbazone as commercially not available. When re-viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 26 June 2015, or, if that reference standard is not commercially available by that date, the unavailability of it. (pt)
has substance code
  • S019100
is legislated by
is member of
is is member of of
is legislates of
is linked to of
is residue of
Faceted Search & Find service v1.16.115 as of Sep 26 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Sep 26 2023, on Linux (x86_64-generic_glibc25-linux-gnu), Single-Server Edition (126 GB total memory, 108 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software